Best in Biotech 19 Nov 2024
Six bispecific antibody companies you should know about
Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.
Cancer
- Latest Posts
In Depth 18 Nov 2024
What is Abcam’s founder, Jonathan Milner, up to?
Since Abcam was acquired in December 2023, its founder, Jonathan Milner has been very active. Delve into his investment strategy.
Best in Biotech 14 Nov 2024
8 biotech companies advancing new treatments for breast cancer in 2024
Delve into the diverse landscape of breast cancer treatment with nine biotech companies currently developing new treatments.
In Depth 5 Nov 2024
From consumer health to pure biopharma: Inside Sanofi’s strategic shift
Delve into Sanofi’s “play to win” strategy as investments are ramping up after their consumer health division’s divestment.
News and Trends 4 Nov 2024
Top biotech deals of October 2024
Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024.
Best in Biotech 31 Oct 2024
Five T cell engager companies you should know about
Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.
ADVERTISEMENT
ADVERTISEMENT
In Depth 30 Oct 2024
Spatial Transcriptomics: A window into disease
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease?
Best in Biotech 29 Oct 2024
GPCR therapies: Eight promising biotechs hacking the cell signaling pathway
In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused pipelines.
Best in Biotech 22 Oct 2024
Eight nanotechnology companies to watch out for
Here are eight nanotechnology companies that are widening the scope in medicine, that you should know about.
In Depth 18 Oct 2024
The AI boom in cancer: Game-changer or just hype?
Is AI just hype or a game-changer? Delve into AI’s contribution to oncology, from diagnostics to drug discovery and personalized treatment.
Best in Biotech 17 Oct 2024
Top six European biotech entrepreneurs to know in 2024 (according to VCs)
We reached out to VCs to nominate prominent European entrepreneurs in the biotech industry who are committed to bringing potentially life-changing treatments to market.
In Depth 16 Oct 2024
JAK inhibitors: Are they a good option for treating inflammatory diseases and cancer?
Find out more about JAK inhibitors and whether they are a good option for treating inflammatory diseases and cancer.
ADVERTISEMENT
